ArticleTrials2022

Symptom-driven inhaled corticosteroid/long-acting beta-agonist therapy for adult patients with asthma who are non-adherent to daily maintenance inhalers: a study protocol for a pragmatic randomized controlled trial.

James G Krings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.